Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure: the PRECISE trial
Background Carvedilol has improved the symptomatic status of patients with moderate to
severe heart failure in single-center studies, but its clinical effects have not been evaluated …
severe heart failure in single-center studies, but its clinical effects have not been evaluated …
Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized …
M Packer, WS Colucci, JD Sackner-Bernstein… - Circulation, 1996 - europepmc.org
Background Carvedilol has improved the symptomatic status of patients with moderate to
severe heart failure in single-center studies, but its clinical effects have not been evaluated …
severe heart failure in single-center studies, but its clinical effects have not been evaluated …
[引用][C] Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure: The PRECISE trial
M PACKER, WS COLUCCI… - … (New York, NY), 1996 - pascal-francis.inist.fr
Author PACKER, M 1; COLUCCI, W. S 2; GOTTLIEB, S. S 9; PEARLE, D 10; CODY, R. J 11;
GREGORY, J. J 12; KANTROWITZ, N. E 6; LEJEMTEL, T. H; YOUNG, S. T 13 14; LUKAS, M …
GREGORY, J. J 12; KANTROWITZ, N. E 6; LEJEMTEL, T. H; YOUNG, S. T 13 14; LUKAS, M …
Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure: The PRECISE Trial
M Packer, WS Colucci, JD Sackner-Bernstein… - …, 1996 - researchwithrutgers.com
Background: Carvedilol has improved the symptomatic status of patients with moderate to
severe heart failure in single-center studies, but its clinical effects have not been evaluated …
severe heart failure in single-center studies, but its clinical effects have not been evaluated …
Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized …
M Packer, WS Colucci, JD Sackner-Bernstein… - …, 1996 - pubmed.ncbi.nlm.nih.gov
Background Carvedilol has improved the symptomatic status of patients with moderate to
severe heart failure in single-center studies, but its clinical effects have not been evaluated …
severe heart failure in single-center studies, but its clinical effects have not been evaluated …
Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure: The PRECISE Trial
M Packer, WS Colucci… - …, 1996 - utsouthwestern.elsevierpure.com
Background: Carvedilol has improved the symptomatic status of patients with moderate to
severe heart failure in single-center studies, but its clinical effects have not been evaluated …
severe heart failure in single-center studies, but its clinical effects have not been evaluated …
Double-Blind, Placebo-Controlled Study of the Effects of Carvedilol in Patients With Moderate to Severe Heart Failure
M Packer, WS Colucci, JD Sackner-Bernstein, C Liang… - Circulation, 1996 - cir.nii.ac.jp
< jats: p>< jats: italic> Background</jats: italic> Carvedilol has improved the symptomatic
status of patients with moderate to severe heart failure in single-center studies, but its clinical …
status of patients with moderate to severe heart failure in single-center studies, but its clinical …
[引用][C] Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial (Prospective Randomized …
M PACKER - Circulation, 1996 - cir.nii.ac.jp
Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to
severe heart failure. The PRECISE Trial (Prospective Randomized Evaluation of Carvedilol on …
severe heart failure. The PRECISE Trial (Prospective Randomized Evaluation of Carvedilol on …